Nutrien Ltd (NTR) — Titan Protect Analysis

NTR

Nutrien Ltd

Basic Materials · ·

$67.20

Data: 2026-06-03

✓ ETHICAL PASS

NARROW MOAT

LIMITED

Data Confidence: 0.0%

Key Metrics

How this company measures up on the fundamentals that matter

Market Cap

$33.5B

Total market value of the company

Trailing P/E

14.20

Reasonably valued

Forward P/E

13.07

Based on estimated future earnings — lower means cheaper

Rev Growth

+19.0%

Year-over-year revenue change

Profit Margin

8.9%

How much profit the company keeps from each dollar of revenue

ROE

9.8%

Return on equity — how efficiently it uses shareholder money

Analyst Target

$82.50

+23% from current price — median analyst estimate

Recommendation

BUY

Consensus view from 20 analysts covering this stock

About Nutrien Ltd

Nutrien Ltd. provides crop inputs and services. The company operates through four segments: Retail, Potash, Nitrogen, and Phosphate. The Retail segment markets crop nutrients, crop protection products, seed, and merchandise, as well as provides agronomic application and financing services and solutions; and produces proprietary products, including proprietary crop nutrient, crop protection, and seed products. The Potash segment includes mining and processing of potash. The Nitrogen segment owns

https://www.nutrien.com

Country: Canada Industry: Agricultural Inputs

Ethical Screening

Five compliance checks based on AAOIFI standards — all must pass for ethical clearance

Business Activity

PASS

Core business does not involve prohibited activities

Debt Ratio

0.0% PENDING

Debt must be below 33% of total assets

Cash Ratio

0.0% PENDING

Interest-bearing cash below 33% of assets

Receivables

0.0% PENDING

Receivables below 49% of assets

Revenue Purity

0.0% PENDING

Non-compliant revenue below 5% — any excess requires purification

Quantitative Intelligence

Statistical analysis of price behaviour, risk, and market regime — independent of fundamental data

Regime

DISTRIBUTION

Smart money appears to be selling into strength — caution

Sharpe Ratio

0.618

Good returns relative to risk taken

Kelly Fraction

0.0474

Modest edge detected — smaller position warranted

Calmar Ratio

0.762

Acceptable balance between returns and drawdown risk

Annual Return

14.8%

Historical annualised return based on price data

Max Drawdown

-19.5%

Largest peak-to-trough decline — the worst it has been

HMM State

CRISIS

Elevated risk detected — extreme caution warranted

Days in State

How long the current regime has persisted — longer means more stable

Market Data

Trading characteristics and market positioning

Beta

1.10

Moves slightly more than the broader market

52W High

$85.36

21% below the year high

52W Low

$53.03

27% above the year low

Avg Volume

3,544,450

Average daily shares traded — higher means easier to buy and sell

Short Ratio

0.9

Days it would take all short sellers to cover — higher means more crowded

Short % Float

N/A

Div Yield

321.0%

Annual dividend as a percentage of the share price

EPS (TTM)

$4.91

Earnings per share over the last 12 months

Financial Health

Balance sheet strength and cash generation — the foundation of long-term value

Debt/Equity

55.36

Heavy leverage — higher financial risk if revenues decline

Current Ratio

N/A

Quick Ratio

N/A

Like current ratio but excludes inventory — stricter test

Gross Margin

32.3%

Revenue left after cost of goods — higher means pricing power

Operating Margin

6.5%

Profit from core operations before interest and tax

Free Cash Flow

$1.6B

Positive — the business generates more cash than it spends

Revenue (TTM)

$26.9B

Total revenue over the last 12 months

Net Income

$2.4B

Profitable — the bottom line is positive

Analyst Coverage

Analysts

Target High

$96.00

Target Median

$82.50

Target Low

$61.00

Political Trading Activity

Congressional trading disclosures involving this instrument

Date	Politician	Party	Type	Amount
30 Apr2026	Dave McCormick	Republican	sell	500K–1M

Source: Congressional disclosure filings. View all political trades at

Insider Intelligence

Explore the Ethical Screener View Track Record

Data sourced from public filings and market feeds. Not financial advice. Updated: 2026-06-03

Before you go